Evolving global and national criteria for identifying a suspected case of COVID-19.
Asia
/ epidemiology
Betacoronavirus
COVID-19
Centers for Disease Control and Prevention, U.S.
Coronavirus Infections
/ diagnosis
Europe
/ epidemiology
Humans
International Cooperation
International Health Regulations
North America
/ epidemiology
Pandemics
Pneumonia, Viral
/ diagnosis
Public Health
/ legislation & jurisprudence
SARS-CoV-2
United States
World Health Organization
Coronavirus disease 2019
clinical characteristics
diagnostic criteria
epidemiological risk
severe acute respiratory syndrome coronavirus 2
study participants
suspected case
Journal
The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
1
9
2020
pubmed:
1
9
2020
medline:
8
9
2020
Statut:
ppublish
Résumé
The outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 and continues to spread worldwide. Rapid and accurate identification of suspected cases is critical in slowing spread of the virus that causes the disease. We aimed to highlight discrepancies in the various criteria used by international agencies and highly impacted individual countries around the world. We reviewed the criteria for identifying a suspected case of COVID-19 used by two international public health agencies and 10 countries across Asia, Europe, and North America. The criteria included information on the clinical causes of illness and epidemiological risk factors. Non-English language guidelines were translated into English by a co-author who is fluent in that particular language. Although most criteria are modifications of World Health Organization recommendations, the specific clinical features and epidemiological risks for triggering evaluation of patients with suspected COVID-19 differed widely among countries. The rationale for these differences may be related to each country's resources, politics, experience with previous outbreaks or pandemics, health insurance system, COVID-19 outbreak severity, and other undetermined factors. We found no consensus regarding the best diagnostic criteria for identifying a suspected case of COVID-19.
Sections du résumé
BACKGROUND
BACKGROUND
The outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 and continues to spread worldwide. Rapid and accurate identification of suspected cases is critical in slowing spread of the virus that causes the disease. We aimed to highlight discrepancies in the various criteria used by international agencies and highly impacted individual countries around the world.
METHODS
METHODS
We reviewed the criteria for identifying a suspected case of COVID-19 used by two international public health agencies and 10 countries across Asia, Europe, and North America. The criteria included information on the clinical causes of illness and epidemiological risk factors. Non-English language guidelines were translated into English by a co-author who is fluent in that particular language.
RESULTS
RESULTS
Although most criteria are modifications of World Health Organization recommendations, the specific clinical features and epidemiological risks for triggering evaluation of patients with suspected COVID-19 differed widely among countries. The rationale for these differences may be related to each country's resources, politics, experience with previous outbreaks or pandemics, health insurance system, COVID-19 outbreak severity, and other undetermined factors.
CONCLUSION
CONCLUSIONS
We found no consensus regarding the best diagnostic criteria for identifying a suspected case of COVID-19.
Identifiants
pubmed: 32865095
doi: 10.1177/0300060520938943
pmc: PMC7469754
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
300060520938943Références
Can Assoc Radiol J. 2020 May;71(2):195-200
pubmed: 32129670
Lancet. 2020 Mar 21;395(10228):945
pubmed: 32142626
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755
pubmed: 32192541
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886